Saptalis utilizes its strong R&D expertise and cGMP manufacturing capabilities in niche areas to provide quality medicines for the customers.
Improving Patients Quality of Life by Innovation
Saptalis Pharmaceuticals, LLC is a U.S. based pharmaceutical company that specializes in the development, manufacturing, and commercialization of niche generic and innovative specialty products. The Company, founded in 2015, has developed a growing commercial product portfolio and pipeline of generic prescription and innovative pharmaceutical products utilizing ANDA and 505 (b)(2) regulatory pathways.
Saptalis Pharmaceuticals features state-of-the-art facilities for the development and manufacturing of oral liquid and topical cream/ointment products for our customers.Saptalis conducts its operations from two facilities located in Hauppauge, NY.
Saptalis utilizes its strong R&D expertise and cGMP manufacturing capabilities in niche areas to provide quality medicines for the customers.
Saptalis Pharmaceuticals, LLC announced today that the FDA approved its ANDA for Metronidazole Vaginal Gel, 0.
Saptalis Pharmaceuticals, LLC announced today that the FDA approved its ANDA for Glycopyrrolate Oral Solution 1mg/5mL ...
Saptalis Pharmaceuticals, LLC, announced today that it has received the U.
Saptalis Pharmaceuticals, LLC announced today that the FDA approved its ANDA for Lithium Oral Solution USP, 8 mEq/5 mL.